Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content. [electronic resource]
Producer: 20080320Description: e626-30 p. digitalISSN:- 1098-4275
- Adolescent
- Ambulatory Care
- Child
- Child, Preschool
- Cohort Studies
- Dermatomyositis -- diagnosis
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Hospitals, Pediatric
- Humans
- Immunoglobulin A -- metabolism
- Immunoglobulins, Intravenous -- administration & dosage
- Logistic Models
- Male
- Maximum Tolerated Dose
- Multivariate Analysis
- Ontario
- Probability
- Retrospective Studies
- Risk Assessment
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.